secwatch.observer — SEC 8-K summary
======================================

Issuer:     Deciphera Pharmaceuticals, Inc. (—)
CIK:        0001654151
Form:       8-K
Filed at:   2024-04-29T23:59:59+00:00
Accession:  0001193125-24-119762
Event type: m_and_a
Sentiment:  positive
Materiality: 1.00
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Deciphera to be acquired by Ono Pharmaceutical for $25.60/share in cash, ~$2.4B equity value
--------------------------------------------------------------------------------

- Offer price $25.60/share cash, 74.7% premium over April 26 close of $14.65.
- Tender offer for all shares; expected close Q3 2024, subject to antitrust and majority tender.
- Stockholders owning ~28% of shares have agreed to tender in support agreements.
- Deciphera will not host Q1 2024 earnings call; Form 10-Q to be filed in ordinary course.
- Boards of both companies unanimously approved; Deciphera to operate as standalone Ono unit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1654151/000119312524119762/0001193125-24-119762-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1654151/000119312524119762/d831713d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-119762

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer